PTI-110

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePTI-110
Drug Alias NameSystebrylDC-0051PTI-110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerum amyloid A protein inhibitors
TargetsSerum amyloid A protein
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProteotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteotech
Active IndicationsN/A
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A